pre-IPO PHARMA

COMPANY OVERVIEW

Nanna Therapeutics is developing breakthrough medicines for the treatment of age-related diseases, focusing first on those linked to mitochondrial dysfunction, including Parkinson’s disease and Amyotrophic Lateral Sclerosis (ALS).


LOCATION

  • Cambridge, , UK

  • THERAPEUTIC AREAS

  • Cardiovascular Disease
  • Inflammatory DIsease
  • Metabolic DIsorders
  • Neurodegenerative Disease

  • WEBSITE

    https://www.nannatherapeutics.com


    CAREER WEBSITE

    https://www.nannatherapeutics.com/#careers


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Apr 9, 2019

    Nanna Therapeutics Awarded £829,892 Innovate UK Grant to Discover Novel Drugs Leveraging Its Nanoscale Medicines Discovery Engine


    For More Press Releases


    Google Analytics Alternative